Cargando…
The Combination of Stereotactic Body Radiation Therapy and Immunotherapy in Primary Liver Tumors
Treatment recommendations for primary liver malignancies, including hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA), are complex and require a multidisciplinary approach. Despite surgical options that are potentially curative, options for nonsurgical candidates include systemic therapy,...
Autores principales: | Kreidieh, Malek, Zeidan, Youssef H., Shamseddine, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512065/ https://www.ncbi.nlm.nih.gov/pubmed/31182960 http://dx.doi.org/10.1155/2019/4304817 |
Ejemplares similares
-
A phase II single arm study of Nivolumab with stereotactic Ablative radiation Therapy after induction chemotherapy in CHOlangiocarcinoma (NATCHO)
por: Elias, Charbel, et al.
Publicado: (2022) -
Expanding the Scope of Immunotherapy in Colorectal Cancer: Current Clinical Approaches and Future Directions
por: Kreidieh, Malek, et al.
Publicado: (2020) -
Early efficacy of stereotactic body radiation therapy combined with adoptive immunotherapy for advanced malignancies
por: WANG, YI-SHAN, et al.
Publicado: (2013) -
Robotic stereotactic body radiation therapy for liver-limited malignant tumors
por: Frączek, Mariusz, et al.
Publicado: (2014) -
Stereotactic Body radiation therapy for liver tumors with or without rotational intensity modulated radiation therapy
por: Nouhaud, Elodie, et al.
Publicado: (2013)